INTELLIGENT LIVING APPLICATI (ILAG)

KYG4804S1012 - Common Stock

0.4902  +0.02 (+4.14%)

After market: 0.4824 -0.01 (-1.59%)

Fundamental Rating

2

Taking everything into account, ILAG scores 2 out of 10 in our fundamental rating. ILAG was compared to 43 industry peers in the Building Products industry. While ILAG seems to be doing ok healthwise, there are quite some concerns on its profitability. ILAG does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

ILAG had negative earnings in the past year.
ILAG had a negative operating cash flow in the past year.
In the past 5 years ILAG always reported negative net income.
ILAG had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -19.15%, ILAG is not doing good in the industry: 88.37% of the companies in the same industry are doing better.
ILAG has a Return On Equity of -21.35%. This is amonst the worse of the industry: ILAG underperforms 83.72% of its industry peers.
Industry RankSector Rank
ROA -19.15%
ROE -21.35%
ROIC N/A
ROA(3y)-13.9%
ROA(5y)-13.76%
ROE(3y)-23.27%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 9.83%, ILAG is not doing good in the industry: 93.02% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ILAG has grown nicely.
The Profit Margin and Operating Margin are not available for ILAG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.29%
GM growth 5Y7.66%

6

2. Health

2.1 Basic Checks

ILAG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ILAG remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ILAG has about the same amount of shares outstanding.
ILAG has a better debt/assets ratio than last year.

2.2 Solvency

ILAG has an Altman-Z score of 2.63. This is not the best score and indicates that ILAG is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.63, ILAG is not doing good in the industry: 69.77% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.02 indicates that ILAG is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, ILAG belongs to the top of the industry, outperforming 81.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 2.63
ROIC/WACCN/A
WACC11.44%

2.3 Liquidity

A Current Ratio of 8.70 indicates that ILAG has no problem at all paying its short term obligations.
With an excellent Current ratio value of 8.70, ILAG belongs to the best of the industry, outperforming 95.35% of the companies in the same industry.
ILAG has a Quick Ratio of 5.09. This indicates that ILAG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.09, ILAG belongs to the best of the industry, outperforming 95.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.7
Quick Ratio 5.09

0

3. Growth

3.1 Past

The earnings per share for ILAG have decreased strongly by -85.31% in the last year.
ILAG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -66.96%.
The Revenue for ILAG have been decreasing by -14.88% on average. This is quite bad
EPS 1Y (TTM)-85.31%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q58.87%
Revenue 1Y (TTM)-66.96%
Revenue growth 3Y-16.88%
Revenue growth 5Y-14.88%
Revenue growth Q2Q-62.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ILAG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ILAG!.
Industry RankSector Rank
Dividend Yield N/A

INTELLIGENT LIVING APPLICATI

NASDAQ:ILAG (5/17/2024, 7:05:56 PM)

After market: 0.4824 -0.01 (-1.59%)

0.4902

+0.02 (+4.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.85M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.15%
ROE -21.35%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 9.83%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 8.7
Quick Ratio 5.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-85.31%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-66.96%
Revenue growth 3Y-16.88%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y